These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 25716702)

  • 21. A method for evaluating the cost-benefit of different preparedness planning policies against pandemic influenza.
    Panovska-Griffiths J; Grieco L; van Leeuwen E; Grove P; Utley M
    MethodsX; 2020; 7():100870. PubMed ID: 32280602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Making trials part of good clinical care: lessons from the RECOVERY trial.
    Pessoa-Amorim G; Campbell M; Fletcher L; Horby P; Landray M; Mafham M; Haynes R
    Future Healthc J; 2021 Jul; 8(2):e243-e250. PubMed ID: 34286192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What does a department need to get involved in clinical trials?
    Sancheti P; Aiyer S; Sanghavi S; Gupta A; Shyam A
    Injury; 2023 May; 54 Suppl 3():S46-S50. PubMed ID: 36725487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK.
    Jandu R; Naraynassamy C; Sreeharan N
    Pharmaceut Med; 2022 Oct; 36(5):275-278. PubMed ID: 35902537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity Analysis of the Parameters of Korea's Pandemic Influenza Preparedness Plan.
    Chu C; Lee J; Choi DH; Youn SK; Lee JK
    Osong Public Health Res Perspect; 2011 Dec; 2(3):210-5. PubMed ID: 24159475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Publication Ethics During Public Health Emergencies Such as the COVID-19 Pandemic.
    Smith MJ; Upshur REG; Emanuel EJ
    Am J Public Health; 2020 May; 110(7):e1-e2. PubMed ID: 32407155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translating evidence into practice during the COVID-19 pandemic: pitfalls and mileages.
    Mangoni AA; Erre GL
    Ther Adv Drug Saf; 2021; 12():2042098621998876. PubMed ID: 33796258
    [No Abstract]   [Full Text] [Related]  

  • 28. SOME CLINICAL FEATURES OF THE PRESENT PANDEMIC OF INFLUENZA AS COMPARED WITH THE PANDEMIC OF THIRTY YEARS AGO.
    Lisser H
    Cal State J Med; 1919 Jul; 17(7):231-6. PubMed ID: 18737933
    [No Abstract]   [Full Text] [Related]  

  • 29. Influenza pandemic planning and the paediatrician.
    Ford-Jones EL; Williams R; Tam T; Yaffe B; Naus M; Tamblyn S
    Paediatr Child Health; 2000 Sep; 5(6):315-8. PubMed ID: 20177545
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of vaccination on influenza-related respiratory failure and mortality in hospitalized elderly patients over the 2013-2014 season.
    Joshi M; Chandra D; Mittadodla P; Bartter T
    Open Respir Med J; 2015; 9():9-14. PubMed ID: 25763116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial.
    van Boxtel RA; Verdijk P; de Boer OJ; van Riet E; Mensinga TT; Luytjes W
    Hum Vaccin Immunother; 2015; 11(4):983-90. PubMed ID: 25751506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Origins and Evolutionary Dynamics of H3N2 Canine Influenza Virus.
    Zhu H; Hughes J; Murcia PR
    J Virol; 2015 May; 89(10):5406-18. PubMed ID: 25740996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation.
    Lim WS; Brittain C; Duley L; Edwards S; Gordon S; Montgomery A; Nguyen-Van-Tam J; Read R; Whitham D; Whynes D; Woodhead M; Wootton D
    Health Technol Assess; 2015 Feb; 19(16):1-78, vii-viii. PubMed ID: 25716702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned.
    Ryabkova VA; Churilov LP; Shoenfeld Y
    Clin Immunol; 2021 Feb; 223():108652. PubMed ID: 33333256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Covid-19 pandemic research opportunity: Is the Middle East & North Africa (MENA) missing out?
    Ibrahim H; Kamour AM; Harhara T; Gaba WH; Nair SC
    Contemp Clin Trials; 2020 Sep; 96():106106. PubMed ID: 32781230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review.
    Sigfrid L; Maskell K; Bannister PG; Ismail SA; Collinson S; Regmi S; Blackmore C; Harriss E; Longuere KS; Gobat N; Horby P; Clarke M; Carson G
    BMC Med; 2020 Jun; 18(1):190. PubMed ID: 32586391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advancing preparedness for clinical research during infectious disease epidemics.
    Gobat N; Amuasi J; Yazdanpanah Y; Sigfid L; Davies H; Byrne JP; Carson G; Butler C; Nichol A; Goossens H
    ERJ Open Res; 2019 Apr; 5(2):. PubMed ID: 31123684
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinicians' attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza.
    Bradbury N; Nguyen-Van-Tam J; Lim WS
    BMC Health Serv Res; 2018 May; 18(1):311. PubMed ID: 29716584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of adjuvant immunomodulatory agents for treatment of severe influenza.
    Hui DS; Lee N; Chan PK; Beigel JH
    Antiviral Res; 2018 Feb; 150():202-216. PubMed ID: 29325970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial.
    Lim WS; Meakin G; Brittain C; Bewick T; Duley L
    Trials; 2017 Nov; 18(1):546. PubMed ID: 29145878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.